• Протек
  • Протек 2
  • Протек 4

CV PROTEK will improve the accessibility of goods and increase inventory turnover.

CV PROTEK, the largest distributor of pharmaceuticals and medical products in Russia has implemented a package of JDA software to optimize the supply chains and demand forecasting.

National distributor CV PROTEK and JDA Software Group, Inc., the leader in supply chain management solutions, announced the successful implementation of a software package comprising of JDA® Demand, JDA® Demand Classification, JDA® Fulfillment, JDA® Production & Sourcing Optimization, JDA® Platform, and JDA® Monitor, which allows optimizing supply chains and demand forecasting. The JDA solutions will help improve daily operations by providing more accurate calculations on demand and will support a managerable and flexible logistics system of CV PROTEK, which covers the whole territory of the Russian Federation.

“Few companies offer such a wide range of products as CV PROTEK and cover such a large geographic market,” Stanislav Krupnik, JDA’s Executive for Russia and the CIS, said. "We are glad that the package of JDA solutions will help CV PROTEK make considerable decisions based on real and dynamically changing consumer demand across all distribution channels.”

"When choosing the package of JDA solutions, the priority task was to increase the availability of goods and the inventory turnover to ensure high quality of services to partners and customers, in parallel, minimizing costs,” Viktor Gorbunov, Deputy General Director in charge of Information Technologies of CV PROTEK, noted. “We believe that using JDA solutions PROTEK will be able to track the amount of stock at each point more accurately and constantly improve its activities.”

Vadim Yakunin: “debt bubble” of pharmacies reached the critical volume of 1.7 billion dollars

Vadim Yakunin named problems which brought the Russian pharmaceutical market to the edge of global collapse: no... more...

CV PROTEK is atop the distributors rating in 2017

In 2017 the company accounted for 18.4% share of the direct sales market, with 7.1% increase of direct sales. ... more...

ProApteka and Rigla launched an electronic trading project

The project is being carried out at the Sberbank AST electronic platform (www.sb... more...